GILD US3755581036

Report

Delayed Nasdaq - 04:00:00 2023-01-30 pm EST
83.35	USD		-0.45%

12:06p	Arcellx, Kite Close Deal to Jointly Develop, Commercialize Cell Therapy Treatment for Multiple Myeloma	MT
10:00a	UBS Adjusts Gilead Sciences Price Target to $85 From $71, Maintains Neutral Rating	MT
09:24a	AHF Protests Target Gilead CEO's Drug Profiteering	AQ

Calendar

Event chart GILEAD SCIENCES, INC.

Upcoming events on GILEAD SCIENCES, INC.

02/02/23		FY 2022 Earnings Release
02/02/23 \| 04:30pm		FY 2022 Earnings Call
02/14/23 \| 11:20am		SVB Securities Global Biopharma Conference
02/28/23		Wells Fargo West Coast Biotech Tour
03/07/23 \| 11:10am		Cowen Health Care Conference
03/15/23 \| 09:15am		Barclays Global Healthcare Conference
05/04/23		Q1 2023 Earnings Release (Projected)
08/01/23		Interim 2023 Earnings Release (Projected)
10/26/23		Q3 2023 Earnings Release (Projected)
02/06/24		FY 2023 Earnings Release (Projected)

Past events on GILEAD SCIENCES, INC.

01/09/23 \| 01:30pm		JP Morgan Healthcare Conference
12/20/22 \| 05:00pm		ARC-7 Phase 2 Study Results Call
12/14/22		Ex-dividend day for
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4627
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4667
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4660
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4610
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4635
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4199
12/12/22 \| 06:00pm		American Society of Hematology Meeting - Abstract #4284

Past dividends on GILEAD SCIENCES, INC.

12/14/22		Quarterly 0.73 USD
09/14/22		Quarterly 0.73 USD
06/14/22		Quarterly 0.73 USD
03/14/22		Quarterly 0.73 USD
12/14/21		Quarterly 0.71 USD
09/14/21		Quarterly 0.71 USD
06/14/21		Quarterly 0.71 USD
03/12/21		Quarterly 0.71 USD
12/14/20		Quarterly 0.68 USD
09/14/20		Quarterly 0.68 USD

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread	26 107 25 842 1,0%	22 127 21 839 1,3%	22 449 22 305 0,65%	24 689 24 482 0,84%	27 305 26 673 2,4%	26 518
Operating income (EBITDA) M $	Released Forecast Spread	17 317 16 841 2,8%	12 840 12 564 2,2%	12 468 13 029 -4,3%	13 184 13 142 0,32%	14 598 15 568 -6,2%	13 783
Operating profit (EBIT) M $	Released Forecast Spread	16 031 16 041 -0,06%	11 411 11 753 -2,9%	11 064 11 571 -4,4%	11 704 11 599 0,90%	12 548 13 965 -10%	12 141
Pre-Tax Profit (EBT) M $	Released Forecast Spread	13 529 13 843 -2,3%	7 799 9 060 -14%	5 160 5 333 -3,2%	1 669 1 636 2,0%	8 278 9 507 -13%	5 658
Net income M $	Released Forecast Spread	4 628 10 263 -55%	5 455 7 207 -24%	5 386 4 292 26%	123 137 -10%	6 225 7 205 -14%	4 383
EPS $	Released Forecast Spread	3,51 7,71 -54%	4,17 5,47 -24%	4,22 3,43 23%	0,10 0,12 -16%	4,93 5,75 -14%	3,48
Announcement Date		02/06/2018	02/04/2019	02/04/2020	02/04/2021	02/01/2022	-

Quarterly results

Fiscal Period : December

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q3

2022 Q4

Sales
M $

Released
Forecast
Spread

7 421
6 333
17%

7 244
6 635
9,2%

6 590
6 279
5,0%

6 260
5 873
6,6%

7 042
6 133
15%

6 630

Operating income
(EBITDA)
M $

Released
Forecast
Spread

4 902
3 922
25%

2 042
3 632
-44%

4 049
3 438
18%

3 195
3 183
0,38%

3 811
3 049
25%

2 865

Operating profit
(EBIT)
M $

Released
Forecast
Spread

4 379
3 126
40%

1 507
2 931
-49%

3 524
3 060
15%

2 670
2 602
2,6%

3 286
2 529
30%

2 622

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

3 438
1 953
76%

759
1 966
-61%

-152
2 158
-107%

1 503
1 664
-9,7%

2 432
1 674
45%

1 840

Net income
M $

Released
Forecast
Spread

2 592
1 769
47%

382
1 424
-73%

19,0
1 611
-99%

1 144
1 367
-16%

1 789
1 248
43%

1 438

EPS
$

Released
Forecast
Spread

2,05
1,37
50%

0,30
1,14
-74%

0,02
1,34
-99%

0,91
1,11
-18%

1,42
1,01
41%

1,15

Announcement Date

10/28/2021

02/01/2022

04/28/2022

08/02/2022

10/27/2022

Previous year

Next Year

Upcoming sector events for GILEAD SCIENCES, INC.

02/01/23 \| 12:30am		NOVO NORDISK A/S : FY 2022 Earnings Release
02/02/23 \| 01:00am		ROCHE HOLDING AG : FY 2022 Earnings Release
02/02/23 \| 06:25am		ELI LILLY AND COMPANY : FY 2022 Earnings Release
02/02/23 \| 06:30am		MERCK & CO., INC. : FY 2022 Earnings Release
04/18/23		JOHNSON & JOHNSON : Q1 2023 Earnings Release
04/26/23		ROCHE HOLDING AG : Q1 2023 Sales and Revenue Release
04/27/23 \| 06:25am		ELI LILLY AND COMPANY : Q1 2023 Earnings Release
04/27/23 \| 06:30am		MERCK & CO., INC. : Q1 2023 Earnings Release
05/03/23		NOVO NORDISK A/S : Q1 2023 Earnings Release (Projected)
07/18/23		JOHNSON & JOHNSON : Interim 2023 Earnings Release (Projected)

More events

Past sector events for GILEAD SCIENCES, INC.

01/24/23		JOHNSON & JOHNSON : FY 2022 Earnings Release
11/02/22 \| 01:30am		NOVO NORDISK A/S : Q3 2022 Earnings Release
11/01/22 \| 05:25am		ELI LILLY AND COMPANY : Q3 2022 Earnings Release
10/27/22 \| 06:30am		MERCK & CO., INC. : Q3 2022 Earnings Release
10/18/22 \| 06:25am		JOHNSON & JOHNSON : Q3 2022 Earnings Release
10/18/22 \| 01:00am		ROCHE HOLDING AG : Q3 2022 Sales and Revenue Release
08/04/22 \| 06:25am		ELI LILLY AND COMPANY : Interim 2022 Earnings Release
08/03/22 \| 01:30am		NOVO NORDISK A/S : Interim 2022 Earnings Release
07/28/22 \| 06:30am		MERCK & CO., INC. : Interim 2022 Earnings Release
07/21/22 \| 01:00am		ROCHE HOLDING AG : Interim 2022 Earnings Release

More events

Analysis

Factbox-Advertisers react to Twitter's new ownership